Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2022-05-13 Director's Dealing
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure for corporate insiders (directors/executives) when they acquire or dispose of company shares. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider share transactions and ownership reporting.
2022-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (executive or major shareholder) changes their shareholding position. This corresponds to the 'Director's Dealing' category, which covers insider transactions and ownership reporting.
2022-05-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Bioneer Corporation. It details the meeting date, location, agenda items (approval of director and auditor remuneration limits), and provides information on electronic voting and proxy solicitation. This document is a standard proxy statement/information circular sent to shareholders to solicit votes for an upcoming meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-05-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for upcoming general meetings. It provides information on the meeting agenda (such as director and auditor compensation limits), voting procedures (electronic voting, written proxy), and the solicitation period. This falls directly under the 'Proxy Solicitation & Information Statement' category.
2022-05-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Bioneer, detailing quarterly financial performance (revenue, operating profit, net income) for 2022 Q1. It provides key financial highlights and comparisons to previous periods, which is the standard format for an Earnings Release (ER). It is not a full report, but rather the initial announcement of financial results. Q1 2022
2022-04-29 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice regarding a change in the company's listing category (from 'Technology Growth' to 'Blue Chip' status) on the stock exchange. It does not fit into specific categories like financial reports, dividends, or M&A. As it is a formal regulatory announcement regarding corporate status, it falls under the general regulatory filings category.
2022-04-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.